Review
Published on 23 Sep 2021
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.736123
- 4,209 views
- 7 citations
Type at least 3 characters
1,303 articles
Articles
Case Report
Published on 23 Sep 2021
Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.731429
- 2,635 views
- 6 citations
Mini Review
Published on 23 Sep 2021
Recent Advances in Experimental Dendritic Cell Vaccines for Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.730824
- 14,077 views
- 45 citations
Systematic Review
Published on 23 Sep 2021
The Prediction Potential of the Pretreatment Lung Immune Prognostic Index for the Therapeutic Outcomes of Immune Checkpoint Inhibitors in Patients With Solid Cancer: A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.691002
- 2,203 views
- 10 citations
Review
Published on 23 Sep 2021
Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.582664
- 5,068 views
- 18 citations
Case Report
Published on 22 Sep 2021
Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.693704
- 2,094 views
- 4 citations
Review
Published on 21 Sep 2021
Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.738626
- 3,722 views
- 13 citations
Original Research
Published on 20 Sep 2021
Immune Checkpoint Inhibitors Plus Single-Agent Chemotherapy for Advanced Non-Small-Cell Lung Cancer After Resistance to EGFR-TKI
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.700023
- 3,493 views
- 6 citations
Original Research
Published on 17 Sep 2021
A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.736620
- 6,179 views
- 26 citations
Review
Published on 17 Sep 2021
Immunotherapeutic Potential of T Memory Stem Cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.723888
- 13,476 views
- 26 citations
Original Research
Published on 15 Sep 2021
Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.695006
- 8,484 views
- 14 citations
Original Research
Published on 15 Sep 2021
A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.706915
- 4,853 views
- 8 citations
Systematic Review
Published on 15 Sep 2021
Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.708195
- 4,291 views
- 28 citations
Original Research
Published on 14 Sep 2021
Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Antitumor Immunosuppression of EGFR Wild Type Lung Cancers With Low PD-L1 Expression
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.643503
- 3,752 views
- 3 citations
Review
Published on 13 Sep 2021
Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.721249
- 5,507 views
- 7 citations
Original Research
Published on 10 Sep 2021
Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.661043
- 2,510 views
- 4 citations